S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.
| Image |  |
|---|---|
| Description | scientific article published on 13 April 2018 |
| Author/s |
author: Pawel Dokurno Martin Dyer |
| Publication date | April 13, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |